CURE® Multiple Myeloma 2022 Special Issue 1

To address symptoms from myeloma that is resistant to treatment, education and communication with care teams are key.

Bone pain is a common symptom that patients with multiple myeloma face, but some may find relief with treatments and exercise.

One of the hurdles, according to the study’s lead author, is that many patients with cancer are worried about receiving a placebo in a clinical trial.

In honor of CURE®’s 20th anniversary, we spoke with experts on how the past 20 years have revolutionized multiple myeloma treatment.

Many things can influence a patient’s response to the COVID-19 vaccine, such as their treatments or whether they have a higher tumor burden.

It can be difficult for patients to go about their daily life with this bone pain, so what can help?

As part of its “Speaking Out” video series, CURE® spoke with Throwing Bones founder Kenny Capps about the importance of patient-physician communication during a myeloma journey.

Donna McNutt uses her love of fashion to find confidence and motivation — and shares it with others — after a myeloma diagnosis.

When cancer harms the body’s ability to make antibodies, what does that mean for the efficacy of vaccines?

Durable and deep responses occurred in patients with multiple myeloma after use of a particular CAR-T cell therapy

Maintaining a healthy diet during treatment may help combat side effects.

Although multiple myeloma survival rates have improved over the past 20 years, the survival gap among socioeconomic groups has widened.